神経内分泌機能検査の世界市場（～2026年）

• 英文タイトル：Global Neuroendocrine Function Test Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY03952
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は神経内分泌機能検査のグローバル市場について調査・分析したレポートです。種類別（手術、薬物）市場規模、用途別（病院、クリニック、外来外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別神経内分泌機能検査の競争状況、市場シェア
・世界の神経内分泌機能検査市場：種類別市場規模 2015年-2020年（手術、薬物）
・世界の神経内分泌機能検査市場：種類別市場規模予測 2021年-2026年（手術、薬物）
・世界の神経内分泌機能検査市場：用途別市場規模 2015年-2020年（病院、クリニック、外来外科センター）
・世界の神経内分泌機能検査市場：用途別市場規模予測 2021年-2026年（病院、クリニック、外来外科センター）
・北米の神経内分泌機能検査市場分析：米国、カナダ
・ヨーロッパの神経内分泌機能検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの神経内分泌機能検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の神経内分泌機能検査市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの神経内分泌機能検査市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Novartis、Eli Lilly、Amgen、Ipsen、Roche
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Neuroendocrine function test is a diagnosis process of finding out the neuroendocrine tumor.
Based on treatment type, the global neuroendocrine function test market is segmented surgery and medication. As surgery is widely used in the neuroendocrine function test market. Similarly, based on end user, the market is segmented into, hospitals and ambulatory surgical centers. Hospitals are expected to hold maximum share in the market due to the easy availability of medication and increasing prescription patterns for the treatment of spinal deformities and instabilities.

Market Analysis and Insights: Global Neuroendocrine Function Test Market
The global Neuroendocrine Function Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Neuroendocrine Function Test Scope and Market Size
Neuroendocrine Function Test market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neuroendocrine Function Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Novartis
Eli Lilly
Amgen
Ipsen
Roche
…

Market segment by Type, the product can be split into
Surgery
Medication
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neuroendocrine Function Test Revenue
1.4 Market by Type
1.4.1 Global Neuroendocrine Function Test Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Surgery
1.4.3 Medication
1.5 Market by Application
1.5.1 Global Neuroendocrine Function Test Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Neuroendocrine Function Test Market Perspective (2015-2026)
2.2 Global Neuroendocrine Function Test Growth Trends by Regions
2.2.1 Neuroendocrine Function Test Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Neuroendocrine Function Test Historic Market Share by Regions (2015-2020)
2.2.3 Neuroendocrine Function Test Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Neuroendocrine Function Test Market Growth Strategy
2.3.6 Primary Interviews with Key Neuroendocrine Function Test Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Neuroendocrine Function Test Players by Market Size
3.1.1 Global Top Neuroendocrine Function Test Players by Revenue (2015-2020)
3.1.2 Global Neuroendocrine Function Test Revenue Market Share by Players (2015-2020)
3.1.3 Global Neuroendocrine Function Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Neuroendocrine Function Test Market Concentration Ratio
3.2.1 Global Neuroendocrine Function Test Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Neuroendocrine Function Test Revenue in 2019
3.3 Neuroendocrine Function Test Key Players Head office and Area Served
3.4 Key Players Neuroendocrine Function Test Product Solution and Service
3.5 Date of Enter into Neuroendocrine Function Test Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Neuroendocrine Function Test Historic Market Size by Type (2015-2020)
4.2 Global Neuroendocrine Function Test Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Neuroendocrine Function Test Market Size by Application (2015-2020)
5.2 Global Neuroendocrine Function Test Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Neuroendocrine Function Test Market Size (2015-2020)
6.2 Neuroendocrine Function Test Key Players in North America (2019-2020)
6.3 North America Neuroendocrine Function Test Market Size by Type (2015-2020)
6.4 North America Neuroendocrine Function Test Market Size by Application (2015-2020)

7 Europe
7.1 Europe Neuroendocrine Function Test Market Size (2015-2020)
7.2 Neuroendocrine Function Test Key Players in Europe (2019-2020)
7.3 Europe Neuroendocrine Function Test Market Size by Type (2015-2020)
7.4 Europe Neuroendocrine Function Test Market Size by Application (2015-2020)

8 China
8.1 China Neuroendocrine Function Test Market Size (2015-2020)
8.2 Neuroendocrine Function Test Key Players in China (2019-2020)
8.3 China Neuroendocrine Function Test Market Size by Type (2015-2020)
8.4 China Neuroendocrine Function Test Market Size by Application (2015-2020)

9 Japan
9.1 Japan Neuroendocrine Function Test Market Size (2015-2020)
9.2 Neuroendocrine Function Test Key Players in Japan (2019-2020)
9.3 Japan Neuroendocrine Function Test Market Size by Type (2015-2020)
9.4 Japan Neuroendocrine Function Test Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Neuroendocrine Function Test Market Size (2015-2020)
10.2 Neuroendocrine Function Test Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Neuroendocrine Function Test Market Size by Type (2015-2020)
10.4 Southeast Asia Neuroendocrine Function Test Market Size by Application (2015-2020)

11 India
11.1 India Neuroendocrine Function Test Market Size (2015-2020)
11.2 Neuroendocrine Function Test Key Players in India (2019-2020)
11.3 India Neuroendocrine Function Test Market Size by Type (2015-2020)
11.4 India Neuroendocrine Function Test Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Neuroendocrine Function Test Market Size (2015-2020)
12.2 Neuroendocrine Function Test Key Players in Central & South America (2019-2020)
12.3 Central & South America Neuroendocrine Function Test Market Size by Type (2015-2020)
12.4 Central & South America Neuroendocrine Function Test Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Neuroendocrine Function Test Introduction
13.1.4 Novartis Revenue in Neuroendocrine Function Test Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Eli Lilly
13.2.1 Eli Lilly Company Details
13.2.2 Eli Lilly Business Overview
13.2.3 Eli Lilly Neuroendocrine Function Test Introduction
13.2.4 Eli Lilly Revenue in Neuroendocrine Function Test Business (2015-2020)
13.2.5 Eli Lilly Recent Development
13.3 Amgen
13.3.1 Amgen Company Details
13.3.2 Amgen Business Overview
13.3.3 Amgen Neuroendocrine Function Test Introduction
13.3.4 Amgen Revenue in Neuroendocrine Function Test Business (2015-2020)
13.3.5 Amgen Recent Development
13.4 Ipsen
13.4.1 Ipsen Company Details
13.4.2 Ipsen Business Overview
13.4.3 Ipsen Neuroendocrine Function Test Introduction
13.4.4 Ipsen Revenue in Neuroendocrine Function Test Business (2015-2020)
13.4.5 Ipsen Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview
13.5.3 Roche Neuroendocrine Function Test Introduction
13.5.4 Roche Revenue in Neuroendocrine Function Test Business (2015-2020)
13.5.5 Roche Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Neuroendocrine Function Test Key Market Segments
Table 2. Key Players Covered: Ranking by Neuroendocrine Function Test Revenue
Table 3. Ranking of Global Top Neuroendocrine Function Test Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Neuroendocrine Function Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Surgery
Table 6. Key Players of Medication
Table 7. Global Neuroendocrine Function Test Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Neuroendocrine Function Test Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Neuroendocrine Function Test Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Neuroendocrine Function Test Market Share by Regions (2015-2020)
Table 11. Global Neuroendocrine Function Test Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Neuroendocrine Function Test Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Neuroendocrine Function Test Market Growth Strategy
Table 17. Main Points Interviewed from Key Neuroendocrine Function Test Players
Table 18. Global Neuroendocrine Function Test Revenue by Players (2015-2020) (Million US$)
Table 19. Global Neuroendocrine Function Test Market Share by Players (2015-2020)
Table 20. Global Top Neuroendocrine Function Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroendocrine Function Test as of 2019)
Table 21. Global Neuroendocrine Function Test by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Neuroendocrine Function Test Product Solution and Service
Table 24. Date of Enter into Neuroendocrine Function Test Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Neuroendocrine Function Test Market Size by Type (2015-2020) (Million US$)
Table 27. Global Neuroendocrine Function Test Market Size Share by Type (2015-2020)
Table 28. Global Neuroendocrine Function Test Revenue Market Share by Type (2021-2026)
Table 29. Global Neuroendocrine Function Test Market Size Share by Application (2015-2020)
Table 30. Global Neuroendocrine Function Test Market Size by Application (2015-2020) (Million US$)
Table 31. Global Neuroendocrine Function Test Market Size Share by Application (2021-2026)
Table 32. North America Key Players Neuroendocrine Function Test Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Neuroendocrine Function Test Market Share (2019-2020)
Table 34. North America Neuroendocrine Function Test Market Size by Type (2015-2020) (Million US$)
Table 35. North America Neuroendocrine Function Test Market Share by Type (2015-2020)
Table 36. North America Neuroendocrine Function Test Market Size by Application (2015-2020) (Million US$)
Table 37. North America Neuroendocrine Function Test Market Share by Application (2015-2020)
Table 38. Europe Key Players Neuroendocrine Function Test Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Neuroendocrine Function Test Market Share (2019-2020)
Table 40. Europe Neuroendocrine Function Test Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Neuroendocrine Function Test Market Share by Type (2015-2020)
Table 42. Europe Neuroendocrine Function Test Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Neuroendocrine Function Test Market Share by Application (2015-2020)
Table 44. China Key Players Neuroendocrine Function Test Revenue (2019-2020) (Million US$)
Table 45. China Key Players Neuroendocrine Function Test Market Share (2019-2020)
Table 46. China Neuroendocrine Function Test Market Size by Type (2015-2020) (Million US$)
Table 47. China Neuroendocrine Function Test Market Share by Type (2015-2020)
Table 48. China Neuroendocrine Function Test Market Size by Application (2015-2020) (Million US$)
Table 49. China Neuroendocrine Function Test Market Share by Application (2015-2020)
Table 50. Japan Key Players Neuroendocrine Function Test Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Neuroendocrine Function Test Market Share (2019-2020)
Table 52. Japan Neuroendocrine Function Test Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Neuroendocrine Function Test Market Share by Type (2015-2020)
Table 54. Japan Neuroendocrine Function Test Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Neuroendocrine Function Test Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Neuroendocrine Function Test Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Neuroendocrine Function Test Market Share (2019-2020)
Table 58. Southeast Asia Neuroendocrine Function Test Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Neuroendocrine Function Test Market Share by Type (2015-2020)
Table 60. Southeast Asia Neuroendocrine Function Test Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Neuroendocrine Function Test Market Share by Application (2015-2020)
Table 62. India Key Players Neuroendocrine Function Test Revenue (2019-2020) (Million US$)
Table 63. India Key Players Neuroendocrine Function Test Market Share (2019-2020)
Table 64. India Neuroendocrine Function Test Market Size by Type (2015-2020) (Million US$)
Table 65. India Neuroendocrine Function Test Market Share by Type (2015-2020)
Table 66. India Neuroendocrine Function Test Market Size by Application (2015-2020) (Million US$)
Table 67. India Neuroendocrine Function Test Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Neuroendocrine Function Test Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Neuroendocrine Function Test Market Share (2019-2020)
Table 70. Central & South America Neuroendocrine Function Test Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Neuroendocrine Function Test Market Share by Type (2015-2020)
Table 72. Central & South America Neuroendocrine Function Test Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Neuroendocrine Function Test Market Share by Application (2015-2020)
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Product
Table 77. Novartis Revenue in Neuroendocrine Function Test Business (2015-2020) (Million US$)
Table 78. Novartis Recent Development
Table 79. Eli Lilly Company Details
Table 80. Eli Lilly Business Overview
Table 81. Eli Lilly Product
Table 82. Eli Lilly Revenue in Neuroendocrine Function Test Business (2015-2020) (Million US$)
Table 83. Eli Lilly Recent Development
Table 84. Amgen Company Details
Table 85. Amgen Business Overview
Table 86. Amgen Product
Table 87. Amgen Revenue in Neuroendocrine Function Test Business (2015-2020) (Million US$)
Table 88. Amgen Recent Development
Table 89. Ipsen Company Details
Table 90. Ipsen Business Overview
Table 91. Ipsen Product
Table 92. Ipsen Revenue in Neuroendocrine Function Test Business (2015-2020) (Million US$)
Table 93. Ipsen Recent Development
Table 94. Roche Company Details
Table 95. Roche Business Overview
Table 96. Roche Product
Table 97. Roche Revenue in Neuroendocrine Function Test Business (2015-2020) (Million US$)
Table 98. Roche Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neuroendocrine Function Test Market Share by Type: 2020 VS 2026
Figure 2. Surgery Features
Figure 3. Medication Features
Figure 4. Global Neuroendocrine Function Test Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Neuroendocrine Function Test Report Years Considered
Figure 9. Global Neuroendocrine Function Test Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Neuroendocrine Function Test Market Share by Regions: 2020 VS 2026
Figure 11. Global Neuroendocrine Function Test Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Neuroendocrine Function Test Market Share by Players in 2019
Figure 14. Global Top Neuroendocrine Function Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuroendocrine Function Test as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Neuroendocrine Function Test Revenue in 2019
Figure 16. North America Neuroendocrine Function Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Neuroendocrine Function Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Neuroendocrine Function Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Neuroendocrine Function Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Neuroendocrine Function Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Neuroendocrine Function Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Neuroendocrine Function Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

以下、関連資料のご紹介

神経内分泌がんの世界市場（～2026年）

Global Neuroendocrine Carcinoma Market Size, Status and Forecast 2020-2026
MRC2-11QY03951 2020年11月20日 96Pages
当調査資料は神経内分泌がんのグローバル市場について調査・分析したレポートです。種類別（化学療法、ソマトスタチン類似体、標的療法）市場規模、用途別（病院、診療所、腫瘍学センター、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日...

神経内分泌がん治療薬の世界市場（～2026年）

Global Neuroendocrine Carcinoma Drugs Market Insights and Forecast to 2026
MRC2-11QY08111 2020年11月20日 117Pages
当調査資料は神経内分泌がん治療薬のグローバル市場について調査・分析したレポートです。種類別（ソマトスタチン類似体、標的療法、化学療法）市場規模、用途別（病院、診療所、腫瘍学センター、外来手術センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジ...

神経内分泌腫瘍治療薬の世界市場（～2026年）

Global Neuroendocrine Tumor Drug Market Insights and Forecast to 2026
MRC2-11QY08112 2020年11月20日 150Pages
当調査資料は神経内分泌腫瘍治療薬のグローバル市場について調査・分析したレポートです。種類別（神経内分泌腫瘍薬mTORタンパク質阻害剤、チロシンキナーゼ3阻害剤、ソマトスタチン受容体拮抗薬、成長ホルモン放出因子拮抗薬、ソマトスタチン受容体作動薬、その他）市場規模、用途別（病院、診療所、その他）市場規模...

尿検査の世界市場（～2026年）

Global Urinalysis Test Market Size, Status and Forecast 2020-2026
MRC2-11QY04950 2020年11月20日 95Pages
当調査資料は尿検査のグローバル市場について調査・分析したレポートです。種類別（肉眼的尿検査、生化学的尿検査）市場規模、用途別（病気診断、妊娠検査、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、...

LDL検査の世界市場（～2026年）

Global LDL Test Market Size, Status and Forecast 2020-2026
MRC2-11QY12492 2020年11月25日 93Pages
当調査資料はLDL検査のグローバル市場について調査・分析したレポートです。種類別（LDL-C、LDL-P、LDL-B、その他）市場規模、用途別（アテローム性動脈硬化症、肥満、脂質異常症、糖尿病、狭心症、脳卒中、頸動脈疾患、末梢動脈疾患）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フラン...

肝炎検査診断の世界市場（～2026年）

Global Hepatitis Test Diagnosis Market Size, Status and Forecast 2020-2026
MRC2-11QY12173 2020年11月25日 98Pages
当調査資料は肝炎検査診断のグローバル市場について調査・分析したレポートです。種類別（B型肝炎（HBV）、C型肝炎（HCV）、その他肝炎疾患）市場規模、用途別（病院、ナーシングホーム、診断研究所、血液バンク、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア...

多機能マッサージャーの世界市場（～2026年）

Global Multi-function Massagers Market Insights and Forecast to 2026
MRC2-11QY07923 2020年11月20日 114Pages
当調査資料は多機能マッサージャーのグローバル市場について調査・分析したレポートです。種類別（全身、足、顔、その他）市場規模、用途別（家庭、商業）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南...

肝炎検査ソリューションの世界市場（～2026年）

Global Hepatitis Test Solution Market Size, Status and Forecast 2020-2026
MRC2-11QY12174 2020年11月25日 95Pages
当調査資料は肝炎検査ソリューションのグローバル市場について調査・分析したレポートです。種類別（ポリメラーゼ連鎖反応（PCR）、酵素免疫測定法（ELISA）、迅速診断検査（RDT）、等温核酸増幅技術（INAAT）、その他技術）市場規模、用途別（病院、診断研究所、ナーシングホーム、血液バンク、その他）市...

肝炎診断検査の世界市場（～2026年）

Global Hepatitis Diagnostic Test Market Size, Status and Forecast 2020-2026
MRC2-11QY12170 2020年11月25日 97Pages
当調査資料は肝炎診断検査のグローバル市場について調査・分析したレポートです。種類別（血液検査、画像検査、肝生検）市場規模、用途別（病院、商業/民間研究所、血液銀行、診療所、公衆衛生研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中...

EGFR変異検査の世界市場（～2026年）

Global EGFR Mutation Test Market Size, Status and Forecast 2020-2026
MRC2-11QY11750 2020年11月25日 98Pages
当調査資料はEGFR変異検査のグローバル市場について調査・分析したレポートです。種類別（DNAシーケンシング、キット）市場規模、用途別（がん病院、臨床研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリ...

神経内分泌がんの世界市場（～2026年） Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. Many are benign, while some are malignant. They most commonly occur in the intestine, where they are often called carcinoid tumors, but they are also found in the pancreas, lung and the …
神経内分泌がん治療薬の世界市場（～2026年） Market Analysis and Insights: Global Neuroendocrine Carcinoma Drugs Market The global Neuroendocrine Carcinoma Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Neuroendocrine Carcinoma Drugs Scope and Market Size …
多機能マッサージャーの世界市場（～2026年） Market Analysis and Insights: Global Multi-function Massagers Market The global Multi-function Massagers market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Multi-function Massagers Scope and Market Size Multi-function Mas…
神経内分泌腫瘍治療薬の世界市場（～2026年） Market Analysis and Insights: Global Neuroendocrine Tumor Drug Market The global Neuroendocrine Tumor Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Neuroendocrine Tumor Drug Scope and Market Size Neuroendocrine …
肝炎検査診断の世界市場（～2026年） Hepatitis is generally classified into two types based on the duration for which the patient suffers. If the condition lasts for less than six months, then it is classified as acute, when the condition persists for more than six months, then it is a case of chronic condition. Hepatitis testing refer…